Cargando…

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?

Polygenic risk scores (PRS) for disease risk stratification show great promise for application in general populations, but most are based on data from individuals of White European origin. We assessed two well validated PRS (SNP18, SNP143) in the Predicting‐Risk‐of‐Cancer‐At‐Screening (PROCAS) study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, D. Gareth, van Veen, Elke M., Byers, Helen, Roberts, Eleanor, Howell, Anthony, Howell, Sacha J., Harkness, Elaine F., Brentnall, Adam, Cuzick, Jack, Newman, William G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Cancer Genetics and Epigenetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290473/ https://www.ncbi.nlm.nih.gov/pubmed/34460111 http://dx.doi.org/10.1002/ijc.33782

Ejemplares similares

A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
por: Brentnall, Adam R., et al.
Publicado: (2019)

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
por: Evans, D Gareth, et al.
Publicado: (2022)

Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester
por: Pegington, Mary, et al.
Publicado: (2023)

Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK
por: Evans, D. Gareth, et al.
Publicado: (2018)

A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies
por: Wang, Chao, et al.
Publicado: (2017)

Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds
por: Wang, Chao, et al.
Publicado: (2018)

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
por: Crosbie, Emma J., et al.
Publicado: (2020)

Molecular progression to cervical precancer, epigenetic switch or sequential model?
por: Nedjai, Belinda, et al.
Publicado: (2018)

Extended gene panel testing in lobular breast cancer
por: van Veen, Elke M., et al.
Publicado: (2021)

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
por: Brentnall, Adam R., et al.
Publicado: (2020)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
por: Woodward, Emma R., et al.
Publicado: (2021)

Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population
por: Qin, Zixin, et al.
Publicado: (2022)

Germline variation in BRCA1/2 is highly ethnic‐specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients
por: Bhaskaran, Shanmuga Priya, et al.
Publicado: (2019)

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials
por: Cuzick, Jack, et al.
Publicado: (2017)

The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study
por: Atakpa, Emma C., et al.
Publicado: (2021)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Risk factors. Introduction to Session 1
por: Howell, Anthony, et al.
Publicado: (2009)

Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom)
por: Renehan, Andrew G., et al.
Publicado: (2020)

Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
por: Wang, Shengfeng, et al.
Publicado: (2019)

A comparison of five methods of measuring mammographic density: a case-control study
por: Astley, Susan M., et al.
Publicado: (2018)

Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
por: Bonde, Jesper, et al.
Publicado: (2020)

Use of the concordance index for predictors of censored survival data
por: Brentnall, Adam R, et al.
Publicado: (2016)

Risk Models for Breast Cancer and Their Validation
por: Brentnall, Adam R., et al.
Publicado: (2020)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer
por: Pegington, Mary, et al.
Publicado: (2022)

Early stopping of clinical trials
por: Cuzick, Jack, et al.
Publicado: (2005)

Impact of DNA damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2020)

SNPs for breast cancer risk assessment
por: Cuzick, Jack, et al.
Publicado: (2017)

Breast cancer risk feedback to women in the UK NHS breast screening population
por: Evans, D Gareth R, et al.
Publicado: (2016)

Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I
por: Warwick, Jane, et al.
Publicado: (2014)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Estimating efficacy in trials with selective crossover
por: Brentnall, Adam R., et al.
Publicado: (2017)

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
por: Gareth Evans, D., et al.
Publicado: (2023)

Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
por: Gareth Evans, D., et al.
Publicado: (2023)

Commentary: Polygenic risk for breast cancer: in search for potential clinical utility
por: Wang, Tingting, et al.
Publicado: (2021)

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort
por: Brentnall, Adam R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7kl1h5u309oqokod0533i9rcah